Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-006747
Filing Date
2013-02-06
Accepted
2013-02-06 13:26:25
Documents
2
Period of Report
2013-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5440
2 POA DOCUMENT poa.txt EX-24.3_456147 4075
  Complete submission text file 0001209191-13-006747.txt   10960
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1522 217TH PLACE SE SUITE 100 BOTHELL WA 98021
Business Address
Wyrick Susan D. (Reporting) CIK: 0001568605 (see all company filings)

Type: 3 | Act: 34 | File No.: 033-80623 | Film No.: 13577107